Move for Surgery (MFS): Evaluating the Use of Wearable Technology for Preconditioning Before Thoracic Surgery

Lung Cancer, Nonsmall Cell Clinical Trial

Official title:

Move for Surgery (MFS): Evaluating the Use of Wearable Technology for Preconditioning Before Thoracic Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03902834
• Other study ID #: BFCRS-333417
• Status: Completed
• Phase: N/A
• Start date: November 30, 2017
• Est. completion date: September 12, 2018

Study information

• Verified date: April 2019
• Source: St. Joseph's Healthcare Hamilton
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Wearable technology is increasingly being used to promote healthy behaviour. In this study, the investigators propose the development and evaluation of Move for Surgery, which utilizes a wearable activity bracelet (Fitbit) and proven behavioural change techniques, for preconditioning of patients prior to lung cancer surgery. The primary outcome of this study will be compliance with Move for Surgery, as a surrogate measure for feasibility. Secondary outcomes, including accrual rates, perioperative pulmonary complications, cost per patient, and patient satisfaction, will also be collected. The investigators have partnered with the Canadian Partnership Against Cancer (CPAC) and Lung Cancer Canada (LCC) to develop Move for Surgery. The ultimate goal of this preliminary study is to lay the groundwork for a subsequent comparative trial to evaluate the impact of Move for Surgery on postoperative complications in the thoracic surgery population.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 25
• Est. completion date: September 12, 2018
• Est. primary completion date: September 12, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Eligible participants include patients with NSCLC set to undergo pulmonary resection.

Exclusion Criteria:

• There will be no exclusion based on functional status in this feasibility study; rather, a subsequent analysis of participant demographics will be performed to inform future phases of this study.

Related Conditions & MeSH terms

• Carcinoma, Non-Small-Cell Lung
• Lung Cancer, Nonsmall Cell
• Preconditioning

Intervention

Other:
• Fitbit
Use the wearable technology (Fitbit) and proven behavioural change techniques to precondition patients prior to lung cancer surgery

Locations

Country	Name	City	State
Canada	St. Joseph's Healthcare Hamilton	Hamilton	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
St. Joseph's Healthcare Hamilton

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The feasibility of Move for Surgery, as measured by a rate of compliance of >70% until program completion.	The feasibility of Move for Surgery, as measured by a rate of compliance of >70% until program completion.	12 months
Secondary	Rate of accrual	Rate of accrual	12 months
Secondary	Perioperative patient complications	Perioperative patient complications	12 months
Secondary	Cost per patient	Cost per patient	12 months
Secondary	Patient-reported health-related quality of life	EuroQol-5Dimensions-5Levels (EQ-5D-5L)	12 months
Secondary	Patient-reported health-related physical activity	International Physical Activity Questionnaire - Short Form (IPAQ-SF)	12 months